2011 Scrip 100: All to play for as new technologies shake up the vaccines market
This article was originally published in Scrip
Executive Summary
New antigen types, novel delivery systems and a shift away from the low-hanging fruit towards more problematic conditions point to healthy prospects in the vaccines space, writes Dr Peter Charlish.